Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
Location: Israel, Center District, Rehovot
Member count: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Tal Ventur... | tal-ventur... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 14.06.2022 | От BioTech... | Биология — одна из самых разви... | - | Елена Ли... | rb.ru/stor... |